Ruedi Aebersold — LLMpedia

Ruedi Aebersold
Name	Ruedi Aebersold
Birth date	1954
Birth place	Zurich, Switzerland
Fields	Proteomics, Systems Biology, Mass Spectrometry
Alma mater	ETH Zurich
Known for	Targeted proteomics, SWATH-MS, SRM/MRM, spectral libraries
Awards	Louis-Jeantet Prize for Medicine, Otto Naegeli Prize, Human Proteome Organization Distinguished Achievement

Contents

Ruedi Aebersold is a Swiss biochemist and proteomics pioneer whose work established targeted mass spectrometry and systems-level proteome analysis. He is known for developing selected reaction monitoring (SRM/MRM), data-independent acquisition (SWATH-MS), and spectral library approaches applied across ETH Zurich, European Molecular Biology Laboratory, Max Planck Society, Broad Institute, and translational efforts with Eli Lilly and Company and Novartis. His research integrates technologies and resources used by Human Genome Project-era initiatives including HUPO, Wellcome Trust, and National Institutes of Health.

Early life and education

Born in Zurich, Aebersold studied at ETH Zurich where he trained in chemistry and biochemistry within laboratories connected to Paul Scherrer Institute and interacted with scientists from Universität Zürich and Swiss Federal Institute of Technology. He completed doctoral and postdoctoral work that overlapped techniques advanced at institutions such as Rockefeller University, Max Planck Institute for Biochemistry, and collaborations with groups at University of California, San Francisco and Stanford University. Early exposure to instrumentation from vendors like Thermo Fisher Scientific, Bruker, and Agilent Technologies shaped his focus on mass spectrometry applications developed alongside peers from Scripps Research Institute and Massachusetts Institute of Technology.

Aebersold established foundational methods in proteomics, integrating targeted strategies like SRM/MRM with discovery platforms such as data-dependent acquisition used by ProteomeXchange, PeptideAtlas, and PRIDE (proteomics). He co-developed technologies and concepts now standard in laboratories at Harvard Medical School, Johns Hopkins University, Columbia University, University of Cambridge, and Karolinska Institutet. His work on quantitative proteomics influenced projects at European Bioinformatics Institute, Genome Institute of Singapore, Broad Institute, and consortia including Human Proteome Organization (HUPO), CPTAC, and IMI. Key innovations include generating assay libraries and targeted assay resources analogous to infrastructures from Ensembl, Uniprot, and Gene Ontology efforts, enabling translational studies in collaboration with clinical centers such as Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and Charité – Universitätsmedizin Berlin. He advanced SWATH-MS (data-independent acquisition) enabling reproducible proteome-wide quantification used in research programs at Dana-Farber Cancer Institute, Salk Institute, Whitehead Institute, CNIO, and industry groups including Pfizer, Roche, and GlaxoSmithKline.

His honors include prizes and memberships from organizations such as the Louis-Jeantet Foundation, the Otto Naegeli Prize, the Human Proteome Organization (HUPO) Distinguished Achievement Award, and recognition from academies like the Royal Society, the European Molecular Biology Organization (EMBO), and the National Academy of Sciences (United States). He has been invited to deliver lectures at venues including Cold Spring Harbor Laboratory, EMBL, Gordon Research Conferences, and symposia organized by Howard Hughes Medical Institute, Wellcome Trust, and European Commission programs. Professional awards from foundations like Alexander von Humboldt Foundation, Friedrich Miescher Institute affiliates, and corporate-academic partnerships with AbbVie and Bayer acknowledge his translational impact.

Aebersold held professorships and leadership roles across institutions including ETH Zurich, Institute of Molecular Systems Biology, Swiss Institute of Bioinformatics, and visiting roles at Massachusetts Institute of Technology, Harvard University, and Stanford University. He cofounded and advised companies and initiatives connected to Biognosys, SCIEX, and collaborative technology transfer with Merck & Co., Novartis, and Eli Lilly and Company. He served on editorial boards for journals and advisory boards for consortia such as Nature Methods, Cell Systems, Molecular & Cellular Proteomics, European Research Council, and funding agencies including European Union Horizon 2020 panels and National Institutes of Health study sections.

His publications describe methods widely used by researchers at University of Oxford, University of California, Berkeley, Yale University, University College London, and University of Toronto. Notable methodological contributions include descriptions of SRM workflows, SWATH-MS implementation, and community resources for spectral libraries and reference assays promoted through ProteomeXchange, PeptideAtlas, PRIDE (proteomics), MassIVE, and collaborative articles involving scientists from Stanford Medicine, UCSF, NIH Clinical Center, and Institute Pasteur. These works interface with databases and standards from UniProt, Gene Ontology Consortium, PSI (Proteomics Standards Initiative), and computational tools developed alongside groups at ETH Zurich, Imperial College London, Max Delbrück Center, and European Bioinformatics Institute.

Aebersold’s mentorship has influenced scientists affiliated with ETH Zurich, EMBL, Max Planck Society, Karolinska Institutet, and numerous academic and industry labs, fostering cross-disciplinary ties to researchers at Harvard Medical School, Broad Institute, Salk Institute, Cold Spring Harbor Laboratory, and Johns Hopkins University. His legacy persists in standards and infrastructures used by Human Proteome Project, clinical proteomics pipelines at Mayo Clinic and Cleveland Clinic, and educational programs at ETH Zurich and Swiss Federal Institutes. The methodologies and community resources he helped build continue to shape research agendas supported by funders such as Wellcome Trust, European Research Council, and National Institutes of Health.

Category:Swiss biochemists Category:Proteomics